Patents by Inventor Kayuri KURODA

Kayuri KURODA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180333466
    Abstract: To provide a therapeutic agent for gastrointestinal disorder such as diabetic gastroparesis. A postprandial gastrokinetic agent containing (A) ghrelin or a ghrelin agonist and (B) motilin or a motilin agonist as active ingredients, in which both the ingredients (A) and (B) are administered so as to act on the stomach after food intake.
    Type: Application
    Filed: July 30, 2018
    Publication date: November 22, 2018
    Applicants: ZERIA PHARMACEUTICAL CO., LTD., SAITAMA UNIVERSITY
    Inventors: Takafumi SAKAI, Ichiro Sakata, Kayuri Kuroda, Makoto Yoshimura
  • Publication number: 20170246257
    Abstract: To provide a therapeutic agent for gastrointestinal disorder such as diabetic gastroparesis. A postprandial gastrokinetic agent containing (A) ghrelin or a ghrelin agonist and (B) motilin or a motilin agonist as active ingredients, in which both the ingredients (A) and (B) are administered so as to act on the stomach after food intake.
    Type: Application
    Filed: May 16, 2017
    Publication date: August 31, 2017
    Applicants: ZERIA PHARMACEUTICAL CO., LTD., SAITAMA UNIVERSITY
    Inventors: Takafumi SAKAI, Ichiro SAKATA, Kayuri KURODA, Makoto YOSHIMURA
  • Patent number: 9682126
    Abstract: To provide a therapeutic agent for gastrointestinal disorder such as diabetic gastroparesis. A postprandial gastrokinetic agent containing (A) ghrelin or a ghrelin agonist and (B) motilin or a motilin agonist as active ingredients, in which both the ingredients (A) and (B) are administered so as to act on the stomach after food intake.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: June 20, 2017
    Assignees: ZERIA PHARMACEUTICAL CO., LTD., SAITAMA UNIVERSITY
    Inventors: Takafumi Sakai, Ichiro Sakata, Kayuri Kuroda, Makoto Yoshimura
  • Publication number: 20160051630
    Abstract: To provide a therapeutic agent for gastrointestinal disorder such as diabetic gastroparesis. A postprandial gastrokinetic agent containing (A) ghrelin or a ghrelin agonist and (B) motilin or a motilin agonist as active ingredients, in which both the ingredients (A) and (B) are administered so as to act on the stomach after food intake.
    Type: Application
    Filed: February 10, 2014
    Publication date: February 25, 2016
    Applicants: ZERIA PHARMACEUTICAL CO., LTD., SAITAMA UNIVERSITY
    Inventors: Takafumi SAKAI, Ichiro SAKATA, Kayuri KURODA, Makoto YOSHIMURA